2 Global Rapid Tests Quarterly Market Size Analysis

• 2.1 Rapid Tests Business Impact Assessment - COVID-19
  • 2.1.1 Global Rapid Tests Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Rapid Tests Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Rapid Tests Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Rapid Tests Headquarters and Area Served
• 3.3 Date of Key Players Enter into Rapid Tests Market
• 3.4 Key Players Rapid Tests Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Rapid Tests Segments, By Type

• 4.1 Introduction
  • 1.4.1 Over-the-counter (OTC) Rapid Test Product
  • 1.4.2 Professional Rapid Test Product
• 4.2 By Type, Global Rapid Tests Market Size, 2019-2021

5 Impact of Covid-19 on Rapid Tests Segments, By Application

• 5.1 Overview
  • 5.5.1 Infectious Disease
  • 5.5.2 Cardiology
  • 5.5.3 Oncology
  • 5.5.4 Pregnancy and Fertility
  • 5.5.5 Toxicology
  • 5.5.6 Glucose Monitoring
  • 5.5.7 Others
• 5.2 By Application, Global Rapid Tests Market Size, 2019-2021
  • 5.2.1 By Application, Global Rapid Tests Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Akers Biosciences, Inc.
  • 7.1.1 Akers Biosciences, Inc. Business Overview
  • 7.1.2 Akers Biosciences, Inc. Rapid Tests Quarterly Revenue, 2020
  • 7.1.3 Akers Biosciences, Inc. Rapid Tests Product Introduction
  • 7.1.4 Akers Biosciences, Inc. Response to COVID-19 and Related Developments
• 7.2 Abbott
  • 7.2.1 Abbott Business Overview
  • 7.2.2 Abbott Rapid Tests Quarterly Revenue, 2020
  • 7.2.3 Abbott Rapid Tests Product Introduction
  • 7.2.4 Abbott Response to COVID-19 and Related Developments
• 7.3 Becton, Dickinson and Company
  • 7.3.1 Becton, Dickinson and Company Business Overview
  • 7.3.2 Becton, Dickinson and Company Rapid Tests Quarterly Revenue, 2020
  • 7.3.3 Becton, Dickinson and Company Rapid Tests Product Introduction
  • 7.3.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
• 7.4 Bio-rad Laboratories, Inc.
  • 7.4.1 Bio-rad Laboratories, Inc. Business Overview
  • 7.4.2 Bio-rad Laboratories, Inc. Rapid Tests Quarterly Revenue, 2020
  • 7.4.3 Bio-rad Laboratories, Inc. Rapid Tests Product Introduction
  • 7.4.4 Bio-rad Laboratories, Inc. Response to COVID-19 and Related Developments
• 7.5 Cepheid, Inc.
  • 7.5.1 Cepheid, Inc. Business Overview
  • 7.5.2 Cepheid, Inc. Rapid Tests Quarterly Revenue, 2020
  • 7.5.3 Cepheid, Inc. Rapid Tests Product Introduction
  • 7.5.4 Cepheid, Inc. Response to COVID-19 and Related Developments
• 7.6 Hologic, Inc.
  • 7.6.1 Hologic, Inc. Business Overview
  • 7.6.2 Hologic, Inc. Rapid Tests Quarterly Revenue, 2020
  • 7.6.3 Hologic, Inc. Rapid Tests Product Introduction
  • 7.6.4 Hologic, Inc. Response to COVID-19 and Related Developments
• 7.7 Meridian Bioscience, Inc.
  • 7.7.1 Meridian Bioscience, Inc. Business Overview
  • 7.7.2 Meridian Bioscience, Inc. Rapid Tests Quarterly Revenue, 2020
  • 7.7.3 Meridian Bioscience, Inc. Rapid Tests Product Introduction
  • 7.7.4 Meridian Bioscience, Inc. Response to COVID-19 and Related Developments
• 7.8 OraSure Technologies, Inc.
  • 7.8.1 OraSure Technologies, Inc. Business Overview
  • 7.8.2 OraSure Technologies, Inc. Rapid Tests Quarterly Revenue, 2020
  • 7.8.3 OraSure Technologies, Inc. Rapid Tests Product Introduction
  • 7.8.4 OraSure Technologies, Inc. Response to COVID-19 and Related Developments
• 7.9 Quidel Corporation
  • 7.9.1 Quidel Corporation Business Overview
  • 7.9.2 Quidel Corporation Rapid Tests Quarterly Revenue, 2020
  • 7.9.3 Quidel Corporation Rapid Tests Product Introduction
  • 7.9.4 Quidel Corporation Response to COVID-19 and Related Developments
• 7.10 Roche Diagnostics
  • 7.10.1 Roche Diagnostics Business Overview
  • 7.10.2 Roche Diagnostics Rapid Tests Quarterly Revenue, 2020
  • 7.10.3 Roche Diagnostics Rapid Tests Product Introduction
  • 7.10.4 Roche Diagnostics Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US

This report covers market size and forecasts of Rapid Tests, including the following market information:
Global Rapid Tests Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Rapid Tests Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Rapid Tests Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Rapid Tests Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Akers Biosciences, Inc., Abbott, Becton, Dickinson and Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc., Quidel Corporation, Roche Diagnostics, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product

Based on the Application:
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others